Kidney Biopsy in HIV: Beyond HIV-Associated Nephropathy

American Journal of Kidney Diseases

Volumn 51, Issue 3, 2008, Pages 504-514

  Fine, Derek M ^a   Perazella, Mark A ^b   Lucas, Gregory M ^a   Atta, Mohamed G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

drug toxicity; Human immunodeficiency virus; kidney biopsy; kidney disease; proteinuria

Indexed keywords

ARTICLE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE COMPLEX DISEASE; KIDNEY BIOPSY; KIDNEY DISEASE; RISK BENEFIT ANALYSIS;

ACUTE DISEASE; ADENINE; AIDS-ASSOCIATED NEPHROPATHY; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOPSY; COMORBIDITY; DIABETIC NEPHROPATHIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION; IMMUNE COMPLEX DISEASES; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; PHOSPHONIC ACIDS; RISK ASSESSMENT; RISK FACTORS;

EID: 39449113013     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.12.005     Document Type: Article

References (68)

1. Estrella M., Fine D.M., Gallant J.E., et al. HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients. Clin Infect Dis 43 (2006) 377-380
2. Ross M.J., and Klotman P.E. Recent progress in HIV-associated nephropathy. J Am Soc Nephrol 13 (2002) 2997-3004
3. Lucas G.M., Eustace J.A., Sozio S., Mentari E.K., Appiah K.A., and Moore R.D. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. AIDS 18 (2004) 541-546
4. Cosgrove C.J., Abu-Alfa A.K., and Perazella M.A. Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy. Am J Med Sci 323 (2002) 102-106
5. Atta M.G., Gallant J.E., Rahman M.H., et al. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant 21 (2006) 2809-2813
6. Selik R.M., Byers Jr. R.H., and Dworkin M.S. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 29 (2002) 378-387
7. US Renal Data System: USRDS 2005 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2005. http://www.usrds.org/2005/pdf/02_incid_prev_05.pdf Accessed August 22, 2007
8. National Diabetes Surveillance System: Incidence of Diabetes. http://www.cdc.gov/diabetes/statistics/incidence/table6.htm Accessed August 30, 2007
9. Centers for Disease Control and Prevention. Racial/ethnic disparities in prevalence, treatment, and control of hypertension-United States, 1999-2002. MMWR Morbid Mortal Wkly Rep 54 (2005) 7-9
10. Atta M.G., Fine D.M., Kirk G.D., Mehta S.H., Moore R.D., and Lucas G.M. Survival on renal replacement therapy among African Americans infected with HIV-1 in urban Baltimore. Clin Infect Dis 45 (2007) 1625-1632
11. Wyatt C.M., Winston J.A., Malvestutto C.D., et al. Chronic kidney disease in HIV infection: An urban epidemic. AIDS 21 (2007) 2101-2103
12. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Cases of HIV Infection and AIDS in the United States. vol 16 (2004). http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2004report/pdf/2004SurveillanceReport.pdf Accessed August 22, 2007
13. Gupta S.K., Eustace J.A., Winston J.A., et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 40 (2005) 1559-1585
14. Jaffe J.A., and Kimmel P.L. Chronic nephropathies of cocaine and heroin abuse: A critical review. Clin J Am Soc Nephrol 1 (2006) 655-667
15. Fine D.M., Garg N., Haas M., et al. Cocaine use and hypertensive renal changes in HIV-infected individuals. Clin J Am Soc Nephrol 2 (2007) 1125-1130
16. Siedner M.A., Atta M.G., Lucas G.M., Perazella M.A., and Fine D.M. Poor validity of urine dipstick as a screening tool for proteinuria in HIV patients. J Acquir Immune Defic Syndr 47 (2008) 261-262
17. Franceschini N., Napravnik S., Eron Jr. J.J., Szczech L.A., and Finn W.F. Incidence and etiology of acute renal failure among ambulatory HIV-infected patients. Kidney Int 67 (2005) 1526-1531
18. Bruggeman L.A., Dikman S., Meng C., Quaggin S.E., Coffman T.M., and Klotman P.E. Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 100 (1997) 84-92
19. Ross M.J., Bruggeman L.A., Wilson P.D., and Klotman P.E. Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy. J Am Soc Nephrol 12 (2001) 2645-2651
20. Barisoni L., Kriz W., Mundel P., and D'Agati V. The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10 (1999) 51-61
21. Winston J.A., Bruggeman L.A., Ross M.D., et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 344 (2001) 1979-1984
22. Ross M.D., and Klotman M.E. HIV-associated nephropathy. AIDS 18 (2004) 1089-1099
23. Monahan M., Tanji N., and Klotman P.E. HIV-associated nephropathy: An urban epidemic. Semin Nephrol 21 (2001) 394-402
24. Ross M.J., Klotman P.E., and Winston J.A. HIV-associated nephropathy: Case study and review of the literature. AIDS Patient Care STDS 14 (2000) 637-645
25. Atta M.G., Choi M.J., Longenecker J.C., et al. Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy. Am J Med 118 (2005) 1288.e21-1288.e26
26. Atta M.G., Longenecker J.C., Fine D.M., et al. Sonography as a predictor of human immunodeficiency virus-associated nephropathy. J Ultrasound Med 23 (2004) 603-610 quiz 612-613
27. Casanova S., Mazzucco G., Barbiano di Belgiojoso G., et al. Pattern of glomerular involvement in human immunodeficiency virus-infected patients: An Italian study. Am J Kidney Dis 26 (1995) 446-453
28. Nochy D., Glotz D., Dosquet P., et al. Renal disease associated with HIV infection: A multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant 8 (1993) 11-19
29. Kimmel P.L., Phillips T.M., Ferreira-Centeno A., Farkas-Szallasi T., Abraham A.A., and Garrett C.T. Brief report: Idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med 327 (1992) 702-706
30. Kimmel P.L., Phillips T.M., Ferreira-Centeno A., Farkas-Szallasi T., Abraham A.A., and Garrett C.T. HIV-associated immune-mediated renal disease. Kidney Int 44 (1993) 1327-1340
31. Kimmel P.L., Barisoni L., and Kopp J.B. Pathogenesis and treatment of HIV-associated renal diseases: Lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann Intern Med 139 (2003) 214-226
32. Roling J., Schmid H., Fischereder M., Draenert R., and Goebel F.D. HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis 42 (2006) 1488-1495
33. Maslo C., Peraldi M.N., Desenclos J.C., et al. Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus. Clin Infect Dis 24 (1997) 350-355
34. Ahmed S., Siddiqui R.K., Siddiqui A.K., Zaidi S.A., and Cervia J. HIV associated thrombotic microangiopathy. Postgrad Med J 78 (2002) 520-525
35. Galpin J.E., Shinaberger J.H., Stanley T.M., et al. Acute interstitial nephritis due to methicillin. Am J Med 65 (1978) 756-765
36. Rossert J. Drug-induced acute interstitial nephritis. Kidney Int 60 (2001) 804-817
37. Von Bargen J., Moorman A., and Holmberg S. How many pills do patients with HIV infection take?. JAMA 280 (1998) 29
38. Perazella M.A. Drug-induced nephropathy: An update. Expert Opin Drug Saf 4 (2005) 689-706
39. Buysen J.G., Houthoff H.J., Krediet R.T., and Arisz L. Acute interstitial nephritis: A clinical and morphological study in 27 patients. Nephrol Dial Transplant 5 (1990) 94-99
40. Cruz D.N., and Perazella M.A. Drug-induced acute tubulointerstitial nephritis: The clinical spectrum. Hosp Pract 33 (1998) 151-152 157-158, 161-164
41. Perazella M.A. Acute renal failure in HIV-infected patients: A brief review of common causes. Am J Med Sci 319 (2000) 385-391
42. Markowitz G.S., and Perazella M.A. Drug-induced renal failure: A focus on tubulointerstitial disease. Clin Chim Acta 351 (2005) 31-47
43. Kopp J.B., Klotman M.E., Adler S.H., et al. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci U S A 89 (1992) 1577-1581
44. Chang H.R., and Pella P.M. Atazanavir urolithiasis. N Engl J Med 355 (2006) 2158-2159
45. Pacanowski J., Poirier J.M., Petit I., Meynard J.L., and Girard P.M. Atazanavir urinary stones in an HIV-infected patient. AIDS 20 (2006) 2131
46. Chan-Tack K.M., Truffa M.M., Struble K.A., and Birnkrant D.B. Atazanavir-associated nephrolithiasis: Cases from the US Food and Drug Administration's Adverse Event Reporting System. AIDS 21 (2007) 1215-1218
47. Couzigou C., Daudon M., Meynard J.L., et al. Urolithiasis in HIV-positive patients treated with atazanavir. Clin Infect Dis 45 (2007) e105-e108
48. Stratta P., Lazzarich E., Canavese C., Bozzola C., and Monga G. Ciprofloxacin crystal nephropathy. Am J Kidney Dis 50 (2007) 330-335
49. Gallant J.E., DeJesus E., Arribas J.R., et al. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N Engl J Med 354 (2006) 251-260
50. Gallant J.E., Staszewski S., Pozniak A.L., et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: A 3-year randomized trial. JAMA 292 (2004) 191-201
51. Gallant J.E., Parish M.A., Keruly J.C., and Moore R.D. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment. Clin Infect Dis 40 (2005) 1194-1198
52. Coca S., and Perazella M.A. Rapid communication: Acute renal failure associated with tenofovir: Evidence of drug-induced nephrotoxicity. Am J Med Sci 324 (2002) 342-344
53. Karras A., Lafaurie M., Furco A., et al. Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: Three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. Clin Infect Dis 36 (2003) 1070-1073
54. Rifkin B.S., and Perazella M.A. Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure. Am J Med 117 (2004) 282-284
55. Schaaf B., Aries S.P., Kramme E., Steinhoff J., and Dalhoff K. Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 37 (2003) e41-e43
56. Verhelst D., Monge M., Meynard J.L., et al. Fanconi syndrome and renal failure induced by tenofovir: A first case report. Am J Kidney Dis 40 (2002) 1331-1333
57. Zimmermann A.E., Pizzoferrato T., Bedford J., Morris A., Hoffman R., and Braden G. Tenofovir-associated acute and chronic kidney disease: A case of multiple drug interactions. Clin Infect Dis 42 (2006) 283-290
58. Stokes M.B., Chawla H., Brody R.I., et al. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am J Kidney Dis 29 (1997) 514-525
59. Cheng J.T., Anderson Jr. H.L., Markowitz G.S., Appel G.B., Pogue V.A., and D'Agati V.D. Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol 10 (1999) 1566-1574
60. Keller C.K., Andrassy K., Waldherr R., and Ritz E. Postinfectious glomerulonephritis-Is there a link to alcoholism?. Q J Med 87 (1994) 97-102
61. Montseny J.J., Meyrier A., Kleinknecht D., and Callard P. The current spectrum of infectious glomerulonephritis. Experience with 76 patients and review of the literature. Medicine (Baltimore) 74 (1995) 63-73
62. Moroni G., Pozzi C., Quaglini S., et al. Long-term prognosis of diffuse proliferative glomerulonephritis associated with infection in adults. Nephrol Dial Transplant 17 (2002) 1204-1211
63. Nasr S.H., Markowitz G.S., Stokes M.B., Said S.M., Valeri A.M., and D'Agati V.D. Acute postinfectious glomerulonephritis in the modern era: Experience with 86 adults and review of the literature. Medicine (Baltimore) 87 (2008) 21-32
64. Stevens L.A., Coresh J., Greene T., and Levey A.S. Assessing kidney function-Measured and estimated glomerular filtration rate. N Engl J Med 354 (2006) 2473-2483
65. Hergesell O., Felten H., Andrassy K., Kuhn K., and Ritz E. Safety of ultrasound-guided percutaneous renal biopsy-Retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant 13 (1998) 975-977
66. Whittier W.L., and Korbet S.M. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 15 (2004) 142-147
67. Manno C., Strippoli G.F., Arnesano L., et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 66 (2004) 1570-1577
68. Whittier W.L., and Korbet S.M. Renal biopsy: Update. Curr Opin Nephrol Hypertens 13 (2004) 661-665